Boltwood Capital Management recently filed their 13F report for the third quarter of 2022, which ended on 2022-09-30.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
220 SANSOME STREET, SUITE 600 SAN FRANCISCO, CA 94104
As of the latest 13F report, the guru’s equity portfolio contained 143 stocks valued at a total of $218.00Mil. The top holdings were SCHF(6.55%), HYGV(4.77%), and MBSD(4.42%).
According to GuruFocus data, these were Boltwood Capital Management’s top five trades of the quarter.
iShares 3-7 Year Treasury Bond ETF
During the quarter, Boltwood Capital Management bought 17,810 shares of NAS:IEI for a total holding of 65,187. The trade had a 0.93% impact on the equity portfolio. During the quarter, the stock traded for an average price of $118.22.
On 10/04/2022, iShares 3-7 Year Treasury Bond ETF traded for a price of $115.18 per share and a market cap of $11.88Bil. The stock has returned -10.81% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
iShares MBS ETF
During the quarter, Boltwood Capital Management bought 17,582 shares of NAS:MBB for a total holding of 59,230. The trade had a 0.74% impact on the equity portfolio. During the quarter, the stock traded for an average price of $96.75.
On 10/04/2022, iShares MBS ETF traded for a price of $92.78 per share and a market cap of $20.14Bil. The stock has returned -13.25% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
FlexShares Disciplined Duration MBS Index Fund
During the quarter, Boltwood Capital Management bought 69,688 shares of ARCA:MBSD for a total holding of 478,333. The trade had a 0.64% impact on the equity portfolio. During the quarter, the stock traded for an average price of $21.01.
On 10/04/2022, FlexShares Disciplined Duration MBS Index Fund traded for a price of $20.3566 per share and a market cap of $100.77Mil. The stock has returned -11.34% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
FlexShares Ready Access Variable Income Fund
During the quarter, Boltwood Capital Management bought 18,025 shares of ARCA:RAVI for a total holding of 50,765. The trade had a 0.61% impact on the equity portfolio. During the quarter, the stock traded for an average price of $74.33.
On 10/04/2022, FlexShares Ready Access Variable Income Fund traded for a price of $74.28 per share and a market cap of $785.67Mil. The stock has returned -1.31% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
SPDR Portfolio Developed World ex-US ETF
During the quarter, Boltwood Capital Management bought 42,475 shares of ARCA:SPDW for a total holding of 313,200. The trade had a 0.5% impact on the equity portfolio. During the quarter, the stock traded for an average price of $28.83.
On 10/04/2022, SPDR Portfolio Developed World ex-US ETF traded for a price of $27.28 per share and a market cap of $10.73Bil. The stock has returned -21.44% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
In terms of valuation, SPDR Portfolio Developed World ex-US ETF has a price-earnings ratio of 12.27 and a price-book ratio of 1.52.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
